PGEN — Precigen Inc · rev $9.7M

Precigen Inc (PGEN) is a biotechnology company listed on US.

Latest reported PGEN revenue for 2025-12-31 was $9.7M. Net income was -$250.6M. PGEN currently screens at market cap $419.2M.

Use this PGEN page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the PGEN quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the PGEN SEC filings page. Lician reads the product cache first so this HTML stays unique to Precigen Inc even when a live quote feed is slow.

Precigen Inc latest statements (FY2025)

Latest cached year on this hub. Full PGEN income, balance, and cash tables.

  • Revenue$9.7M
  • Net Income-$250.6M
  • Total Assets$155.5M
  • Total Debt$0
  • Free Cash Flow-$89.8M